This was corroborated with findings of higher intratumoral IDO expression positively associated with longer survival in renal cell carcinoma-, hepatocellular carcinoma-, and melanoma-patients (3, 67–69). The gene discussed is IDO1; the disease is hereditary clear cell renal cell carcinoma.